Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Telix Pharmaceuticals Limited (NASDAQ: TLX)
TLX Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-4.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
145.90%
TLX Stock Analysis
TLX
PE Ratio:
TLX
PEG Ratio:
Not Available
TLX
Forward EPS Growth (12 month):
0.00%
TLX
PS Ratio:
5.5
TLX
PSG Ratio:
Not Available
TLX
Forward Revenue Growth (12 month):
0.00%
TLX Articles
No data was found